drugset / Trial / NCT01180660

IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery

NCT01180660 ↗

Completed 51 enrolled Northwestern University
RandomizedParallel-groupTriple-blindPrevention

Summary

Can Intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery? The hypotheses:does the use of intraoperative systemic lidocaine decrease postoperative opioid consumption and improve quality of recovery after laparoscopic gastric bypass surgery. This study has the potential to confirm an opioid sparing strategy for morbid obese patients undergoing laparoscopic gastric bypass surgery. The high incidence of obstructive sleep apnea and the increased risk of postoperative hypoxemia make the development of opioid sparing techniques in this patient population warranted.

Timeline

Start
2010-06
Primary completion
2012-10
Completion
2012-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 mg/kg Other

Indications